Early mortality during rifampicin-resistant TB treatment

Early mortality during rifampicin-resistant TB treatment

B A C K G R O U N D: Data suggest that treatment with newer TB drugs (linezolid [LZD], bedaquiline [BDQ] and delamanid [DLM]), used in Khayelitsha, South Africa, since 2012, reduces mortality due to rifampicin-resistant TB (RR-TB). M E T H O D S: This was a retrospective cohort study to assess 6-mon...

Full description

Bibliographic Details
Main Authors: Cox, H. (Author), Cox, V. (Author), Daniels, J. (Author), Furin, J. (Author), Kock, Y. (Author), Mitnick, C. (Author), Mohr-Holland, E. (Author), Reuter, A. (Author), Rodriguez, C.A (Author)
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease 2022
Subjects:
adolescent
adult
Antitubercular Agents
Article
bedaquiline
Bedaquiline
child
cohort analysis
controlled study
death
Death
delamanid
Delamanid
Diarylquinolines
drug resistant tuberculosis
Drug-resistant tuberculosis
female
Female
fluoroquinolone resistance
hospital patient
human
human cell
Humans
infant
linezolid
Linezolid
major clinical study
male
microbial sensitivity test
Microbial Sensitivity Tests
mortality
multidrug resistant tuberculosis
Mycobacterium tuberculosis
quinoline derivative
Retrospective Studies
retrospective study
rifampicin
rifampicin resistance
Rifampin
sex
South Africa
survival
treatment failure
Tuberculosis, Multidrug-Resistant
tuberculostatic agent
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items